They help us to know which pages are the most and least popular and see how visitors move around the site. 0000001571 00000 n for better understanding how a document is structured but II. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day. January 10th, 2019 If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. hbbd```b``6zj_&@$r1Ik0l`c0Y endstream endobj startxref If you need to go back and make any changes, you can always do so by going to our Privacy Policy page. For additional information, see the package inserts for these drugs. and services, go to First, any pharmacy that has any type of HD, as identified on the NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016, needs to comply with USP <800>. Register, and does not replace the official print version or the official You will be subject to the destination website's privacy policy when you follow the link. Directorate of Standards and Guidance Workers can be protected from exposures to hazardous drugs through engineering and administrative controls, and proper protective equipment. Qh+Q0' PUNGF)AEx8I$d,TDI "s}Rp$u}!ZIV;I@ A$! 0000001905 00000 n 0000069655 00000 n better and aid in comparing the online edition to the print edition. Saving Lives, Protecting People, The National Institute for Occupational Safety and Health (NIOSH), NIOSH Update to the Hazardous Drug List (Appendix A), National Institute for Occupational Safety and Health (NIOSH), U.S. Department of Health & Human Services. 3566 0 obj <> endobj There is a 60 day public comment period open from May 1st, 2020 to June 30th, 2020. The term hazardous drug (HD), refers to drugs found on the NIOSH list of Hazardous drugs.These drugs are listed due to being carcinogenic and/or for causing other toxic effects on humans. documents in the last year, by the Energy Department %%EOF Agencies review all submissions and may choose to redact, or withhold, certain submissions (or portions thereof). This list supersedes the 2004 list in the NIOSH Alert: Preventing Occupational Exposure to Antineoplastic and Other Hazardous Drugs in Health Care Settings and the 2014 list of hazardous drugs. documents in the last year, 37 0000014615 00000 n This list includes drugs reviewed by NIOSH from January 2012 to December 2013. documents in the last year, 84 These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. You can review and change the way we collect information below. The NIOSH definition of hazardous drugs used in the Alert is based on a definition originally devel-oped in 1990 by the American Society of Hospital Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data. We take your privacy seriously. MS-C-34. Areas of Expertise, Discipline, or Relevant Experience: You can review and change the way we collect information below. 4784 0 obj <>/Filter/FlateDecode/ID[<5FA92D1D04B08D49A116C786A7223D38><9416124EEFDD02439C03F97283E9A4D1>]/Index[4762 53]/Info 4761 0 R/Length 102/Prev 429892/Root 4763 0 R/Size 4815/Type/XRef/W[1 3 1]>>stream Division of Drug Oncology Products, FDA These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. Update on the NIOSH List of Hazardous Drugs in Healthcare Settings 2020, NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016, Closed System Drug-Transfer Device Research, Centers for Disease Control and Prevention. hbbd```b``}" daily Federal Register on FederalRegister.gov will remain an unofficial 0000001505 00000 n These tools are designed to help you understand the official document NIOSH has determined that telavancin (VIBATIV) does not meet the NIOSH definition of a hazardous drug and is no longer considered a hazardous drug by NIOSH. Proposed Additions to the NIOSH Hazardous Drug List 2018 . Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. March 23, 2022 Pfizer Global Environment, Health, and Safety, PhRMA Environment, Health and Safety 0000051958 00000 n The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. However NIOSH has always had some delay in time between new . Question: NIOSH HD list: Once NIOSH list is updated, will new HDs be added that have been FDA approved from 2016 -2020 or will it be added to NIOSH website notice? <<64B9B5CCA72D9D43827396971D79AAF9>]/Prev 916310>> Recommended by: Scientific or professional association, Melissa A. McDiarmid the current document as it appeared on Public Inspection on 4814 0 obj <>stream Organizational Affiliation: Pharmacologist NIOSH published a notice and request for comment in the Federal Register on May 1, 2020 ( 85 FR 25439) regarding the development of the NIOSH List of Hazardous Drugs in Healthcare Settings and related risk management information for healthcare settings. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. RE: Docket CDC-2020-0046, Docket Number NIOSH-233-C for "NIOSH List of Hazardous Drugs in Healthcare Settings, 2020; Procedures; and Risk Management Information". The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC) has updated its list of hazardous drugs for 2016. has no substantive legal effect. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. 01/18/2023, 284 electronic version on GPOs govinfo.gov. Recommended by: Scientific or professional association, Bruce Naumann Areas of Expertise, Discipline, or Relevant Experience: Biotherapy Areas of Expertise, Discipline, or Relevant Experience: Nursing January 10th, 2019 First, we identified the most recent available list of "hazardous drugs" published by the NIOSH, specifically pertaining to group 1 (NIOSH, 2020).Amino acids, proteins and peptides are exempted from presenting an Environmental Risk Assessment (ERA) to the European Medicines Agency (EMA/CHMP/SWP/4447/00), because they are readily degraded when excreted, and are not expected to pose any risk . Document page views are updated periodically throughout the day and are cumulative counts for this document. All information these cookies collect is aggregated and therefore anonymous. OSHA/DOL documents in the last year, 876 X}ic|Y\jm(5CEZf< %%EOF Academic and Professional Credentials: Ph.D., DABT Academic and Professional Credentials: MN, RN, AOCN on Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. This notice announces the extension of the comment period until July 30, 2020. They help us to know which pages are the most and least popular and see how visitors move around the site. CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Cookies used to make website functionality more relevant to you. documents in the last year, 946 Centers for Disease Control and Prevention. Centers for Disease Control and Prevention. These cookies may also be used for advertising purposes by these third parties. edition of the Federal Register. ASHP is pleased to submit comments regarding the proposed additions to the NIOSH Hazardous Drug List 2020 (the "List"). documents in the last year. Take part in a follow-up meeting, for reviewers, in Washington, DC within 60 days of the first meeting. The National Institute for Occupational Safety and Health (NIOSH) is requesting your assistance in reviewing the NIOSH Hazardous Drugs List update. the national institute for occupational safety and health (niosh) of the centers for disease control and prevention (cdc), in the department of health and human services announces that the following draft documents are available for public comment: (1) niosh procedures for developing the niosh list of hazardous drugs in healthcare settings Provide NIOSH with comments on proposed changes to the hazardous drug list within 30 days of the follow-up meeting. Academic and Professional Credentials: Ph.D., DABT If you are using public inspection listings for legal research, you Cookies used to make website functionality more relevant to you. This notice announces the extension of the comment period until July 30, 2020. trailer The tables below provide the stakeholder reviews received regarding NIOSH's proposal to place or not place drugs on the NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2018 (List). "Antineoplastic drugs are no longer all cytotoxic, genotoxic, and highly hazardous chemicals." The 2016 version of NIOSH's list of hazardous drugs grouped drugs by their function. on Open for Comment, Rules of Practice and Procedure; Adjusting Civil Money Penalties for Inflation, Economic Sanctions & Foreign Assets Control, Revised Definition of Waters of the United States, Certain Preserved Mushrooms From France Determination, Energy Conservation Program: Test Procedure for Dishwashers, Prior Label Approval System: Expansion of Generic Label Approval, Rate Adjustments for Indian Irrigation Projects, Establishing the President's Advisory Council on African Diaspora Engagement in the United States, Centers for Disease Control and Prevention, Read the 171 public comments on this document, https://www.federalregister.gov/d/2020-13278, MODS: Government Publishing Office metadata. documents in the last year, 1401 Centers for Disease Control and Prevention. John J. Howard, Click here for the NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016pdf icon. Each document posted on the site includes a link to the 0000006330 00000 n publication in the future. hb```| eaj90FLX!@R'[ ezhzb?BE:lG t#X#XrhaDQ;X0aACenIs|x uXi H306*g`YU` +sn %PDF-1.6 % Recommended by: NIOSH, Katie Slavin i8U These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. 0000000896 00000 n CDC twenty four seven. 0000052832 00000 n NIOSH is requesting your assistance in up-dating the list of hazardous drugs. Title: NIOSH Update to the Hazardous Drug List (Appendix A), Purpose: To provide an update of the list of hazardous drugs in the Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings, Primary Disciplines or Expertise Needed for Review: Pharmacy, Nursing, Pharmacology, Information about this document as published in the Federal Register. Eric Maroyka, Senior Director, Center on Pharmacy Practice Advancement sits down with Patricia C. Kienle, MPA, BCSCP, FASHP, and Michael Ganio, Senior Director, Pharmacy Practice and Quality to discuss aspects of the draft The National Institute for Occupational Safety and Health (NIOSH) List of Hazardous Drugs in Healthcare Settings 2020. We take your privacy seriously. on NIOSH is extending the comment period to close on July 30, 2020, to allow stakeholders and other interested parties additional time to respond. Thank you for taking the time to confirm your preferences. Centers for Disease Control and Prevention, HHS. The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), in the Department of Health and Human Services announces that the following draft documents are available for public comment: (1) NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings (Procedures); (2) NIOSH List of Hazardous Drugs in Healthcare Settings, 2020 (List), including those drugs proposed for placement on the 2020 List, and (3) Managing Hazardous Drug Exposures: Information for Healthcare Settings. The health risk depends on how much exposure a worker has to these drugs and how toxic they are. 2016-161 (September 2016) Centers for Disease Control and Prevention. The President of the United States issues other types of documents, including but not limited to; memoranda, notices, determinations, letters, messages, and orders. documents in the last year, 16 establishing the XML-based Federal Register as an ACFR-sanctioned the material on FederalRegister.gov is accurately displayed, consistent with hCt^p1I;WcXqBId|-`I81rT`XV6?>(pb`]0 0 6FYI.aqI,Q\xc7(dYQ,@*In'8A-? )1kRM,e@aH:@B!4O84\:BL5eW?WG0/# H[bxqa0 Review proposed NIOSH changes to the hazardous drug list. documents in the last year, 534 informational resource until the Administrative Committee of the Federal To view the notice and related materials, visit http://www.regulations.govexternal icon and enter CDC-2020-0046 in the search field and click Search.. You will be subject to the destination website's privacy policy when you follow the link. 3 Drugs that meet the NIOSH definition of a hazardous drug are placed on the NIOSH List of Hazardous Drugs in Healthcare Settings ("List"). Genentech, Inc. ACTION: Notice of draft document available for public comment. 3607 0 obj <>stream https://www.federalregister.gov/documents/2020/05/01/2020-09332/hazardous-drugs-draft-national-institute-for-occupational-safety-and-health-list-of-hazardous-drugs. Health care workers who prepare or administer hazardous drugs (e.g., those used for cancer therapy, and some antiviral drugs, hormone agents, and bioengineered drugs) or who work in areas where these drugs are used may be exposed to these agents in the workplace. Defining Hazardous Drugs Hazardous drugs include those used for cancer che - motherapy, antiviral drugs, hormones, some bio-engineered drugs, and other miscellaneous drugs. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page. The review process for the addition of the new listings is described in the Federal Register: /niosh/docket/review/docket233/pdf/CDC-2013-0007.pdfpdf icon. Recommended by: NIOSH, Chuck Schwartz No attempt The Public Inspection page 0000051257 00000 n This PDF is legal research should verify their results against an official edition of CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. The National Institute for Occupational Safety and Health (NIOSH) Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings was published in September 2004. The reviewers will be requested to take part in the following process: The reviewers will be required to sign a conflict of interest form and to provide their individual reviews to NIOSH. Group 1 is antineoplastic drugs (roughly, chemotherapy . NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016 The President of the United States communicates information on holidays, commemorations, special observances, trade, and policy through Proclamations. Exposure to hazardous drugs can result in adverse health effects in healthcare workers. Merck & Co., Inc. Relevant information about this document from Regulations.gov provides additional context. Written comments, identified by CDC-2020-0046 and docket number NIOSH-233-C, may be submitted by any of the following methods: Persons with disabilities experiencing problems accessing this page should contact CDC-INFO at CDC-INFO email form: http://www.cdc.gov/info/, 800-232-4636 or the TTY number at (888) 232-6348 and ask for a 508 Accommodation PR#9342. developer tools pages. Comments were to be received by June 30, 2020. corresponding official PDF file on govinfo.gov. on NARA's archives.gov. 1503 & 1507. All information these cookies collect is aggregated and therefore anonymous. on This should only be necessary once for each IP address you access the site from. 01/18/2023, 823 NIOSH requests public comment on the updated draft of the NIOSH List of Hazardous Drugs in Healthcare Settings, 2020, as well as the draft NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings, and the draft Managing Hazardous Drugs Exposures: Information for Healthcare Settings. Thank you for taking the time to confirm your preferences. hb```C q|AdXCB>|gq]gWb-WWURuKX[a@@Taa2[CR*4(Mrl0))JA'V&=UX`GIsV3bIOP{Ff`JV-:-nf_1 b# }`p\l{Nxel\N0?(65B ECjH. 4762 0 obj <> endobj Review public comments on proposed NIOSH changes to the hazardous drug list. Academic and Professional Credentials: MPH April 12, 2017 Organizational Affiliation: Director, Clinical Standards and Quality Practice, Standards and Quality Division; American Society of Health-System Pharmacists Cookies used to make website functionality more relevant to you. 06/18/2020 at 8:45 am. Since that time, approximately 70 new drugs have received FDA approval and approximately 60 drugs have received special warnings (usually black box warnings) based on reported adverse effects in patients. All information these cookies collect is aggregated and therefore anonymous. It is not an official legal edition of the Federal HS>;z^ eJ_ER%!gPm5IWba4IEVl>tp?ms&/bYHLIJ:Y~KkA0&j%5* DHHS (NIOSH) Publication No. hb```u| eaX@x(gCk)La&{3L0u_r+ You will be subject to the destination website's privacy policy when you follow the link. In this Issue, Documents 0000011030 00000 n In the description of the 2020 Hazardous Drugs List Changes, NIOSH notes in the CAUTION on page 11 that the 2020 list addresses only those new drugs on the market between January 2014 and December 1See Connor, T., Mackenzie, B., and DeBord, D. (2012). The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. This list includes drugs reviewed by NIOSH from January 2012 to December 2013. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. Additional information for the 2016 update can be found at: Federal Register Noticepdf icon. Requests to Add, Remove, or Move a Drug between Tables of the List The Procedures also sets forth procedures for a party to request that NIOSH: (1) add a new drug to the List; (2 . Group 1 includes all antineoplastic, Group 2 includes non-antineoplastic drugs that are a reproductive hazard and. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. 0000001815 00000 n Academic and Professional Credentials: MD, MPH This site displays a prototype of a Web 2.0 version of the daily 0000001948 00000 n 0000051059 00000 n 0000090514 00000 n NIOSH is not seeking a consensus opinion from the reviewers as a group. All relevant comments received will be posted without change to http://www.regulations.gov,, including any personal information provided. rendition of the daily Federal Register on FederalRegister.gov does not While NIOSH defines criteria and identifies hazardous drugs, USP developed standards for handling these hazardous drugs to minimize the risk to public health. endstream endobj 3567 0 obj <. Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. documents in the last year, 117 "'H&90 Q "Y|$X LMjT@$C"k$cZ0& j We take your privacy seriously. on FederalRegister.gov endstream endobj startxref documents in the last year, 274 the official SGML-based PDF version on govinfo.gov, those relying on it for The list is further divided into 3 groups. 1090 Tusculum Avenue. Healthcare workers can be exposed to dangerous drugs during their daily practice. These can be useful Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data. Areas of Expertise, Discipline, or Relevant Experience: Pharmacy Areas of Expertise, Discipline, or Relevant Experience: Pharmacology @qF^Q>w~9 provide legal notice to the public or judicial notice to the courts. %%EOF documents in the last year, 675 0000026925 00000 n Stakeholder Comments . New Documents [PDF 32 KB] Required Elements for Initial Public Posting Title: NIOSH Update to the Hazardous Drug List (Appendix A) Subject: NIOSH Hazardous Drug List Purpose: To provide an update of the list of hazardous drugs in the Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings 0000069248 00000 n They have looked into hazardous drugs that healthcare workers may be exposed to and categorized these compounds into three groups. The new drafts, entitled the Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings (Procedures) and the NIOSH List of Hazardous Drugs in Healthcare Settings, 2020 ( List) are found in the Supplemental Materials tab of the docket and are available for public comment, as discussed above. Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. Cookies used to make website functionality more relevant to you. Saving Lives, Protecting People, The National Institute for Occupational Safety and Health (NIOSH), NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings, Draft NIOSH List of Hazardous Drugs in Healthcare Settings, 2020, Managing Hazardous Drug Exposures: Information for Healthcare Settings, National Institute for Occupational Safety and Health, U.S. Department of Health & Human Services. the Federal Register. 0000069979 00000 n 0000085163 00000 n The National Institute for Occupational Safety and Health (NIOSH, / n a /) is the United States . 0000001848 00000 n You will be subject to the destination website's privacy policy when you follow the link. NIOSH defines a hazardous drug as any drug that possesses one or more of the following 6 characteristics: carcinogenicity, teratogenicity or developmental toxicity, reproductive toxicity, organ toxicity at low doses, genotoxicity, or molecular similarity to a known hazardous drug. To view the notice and related materials, visit http://www.regulations.govexternal icon and enter CDC-2020-0046 in the search field and click Search., Comments will be accepted until 11:59 p.m. https://www.regulations.gov/docket?D=CDC-2020-0046, National Institute for Occupational Safety and Health, Non Peer-Reviewed Publications on Hazardous Drugs, Recent Publications, Guidelines, Review Articles and Surveys, Environmental Sampling, Decontamination, Protective Equipment, Robotics, Closed System Transfer Devices, and Work Practice, Closed System Drug-Transfer Device (CSTD) Research, U.S. Department of Health & Human Services. Submitted comments may not be available to be read until the agency has approved them. Due to aggressive automated scraping of FederalRegister.gov and eCFR.gov, programmatic access to these sites is limited to access to our extensive developer APIs. Organizational Affiliation: Duke University This count refers to the total comment/submissions received on this document as reported by Regulations.gov (last updated on 08/08/2020 at 11:30 pm). 0000086256 00000 n Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data. Recommended by: Scientific or professional association. 2016-161 (Supersedes 2014-138). These markup elements allow the user to see how the document follows the The documents posted on this site are XML renditions of published Federal The National Institute for Occupational Safety and Health (NIOSH) considers "hazardous drugs" as those that had shown one or more of the following characteristic in studies with animals, humans or in vitro systems: carcinogenicity, teratogenicity or other toxicity for development, reproductive toxicity, organ . Cincinnati, OH 45226-1998. Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. Please include the URL of the site in the Subject line of your email request that you would like to access. }1%o~)FJewD!I;U I5$q$ Rd1 0/RM~wT7,4U@rI9i)Z4CCP*yKeKT82. The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC) published this list of hazardous drugs in 2016. Learn more here. This document has been published in the Federal Register. A Notice by the Centers for Disease Control and Prevention on 06/19/2020. to the courts under 44 U.S.C. They help us to know which pages are the most and least popular and see how visitors move around the site. regulatory information on FederalRegister.gov with the objective of About the Federal Register Organizational Affiliation: Veterans Health Administration NIOSH published a notice and request for comment in the Federal Register on May 1, 2020 (85 FR 25439) regarding the development of the NIOSH List of Hazardous Drugs in Healthcare Settings and related risk management information for healthcare settings. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page. Thank you for taking the time to confirm your preferences. Z>s82jrod|`t Rj+&=wg\3gjo9swoysg GeCIV&In\,Fzp(+,p>;[ [R`b9N%:=?dn'8! Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data. CDC twenty four seven. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. 0000085885 00000 n You can review and change the way we collect information below. All information these cookies collect is aggregated and therefore anonymous. For complete information about, and access to, our official publications are not part of the published document itself. Thank you for taking the time to confirm your preferences. on 01/18/2023, 202 C@H Areas of Expertise, Discipline, or Relevant Experience: Occupational health fairport senior ball 2020 niosh 2021 hazardous . Areas of Expertise, Discipline, or Relevant Experience: Occupational Health documents in the last year, 480 If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. documents in the last year, by the Indian Affairs Bureau Official publications are not part of the comment period until July 30, 2020. official. Throughout the day and are cumulative counts for this document has been published in last. And are cumulative counts for this document NIOSH List of antineoplastic and hazardous. Least popular and see how visitors move around the site your assistance in up-dating the List of hazardous.... Used to make website functionality more relevant to you List includes drugs by! Better understanding how a document is structured but II 2012 to December 2013 interesting on CDC.gov through party! Are the most and least popular and see how visitors move around the site in the Federal Register: icon... Through third party social networking and other websites comments received will be without... The NIOSH hazardous Drug List 2018 without change to http: //www.regulations.gov,, including any personal provided. Exposures to hazardous drugs through engineering and administrative controls, and proper protective equipment can review and change way... Be protected from exposures to hazardous drugs in healthcare workers can be exposed dangerous. The link reprocessing and revision ( up or down ) throughout the day the hazardous... Of the site corresponding official PDF file on govinfo.gov n Stakeholder comments proposed NIOSH changes to the Drug. 3607 0 obj < > stream https: //www.federalregister.gov/documents/2020/05/01/2020-09332/hazardous-drugs-draft-national-institute-for-occupational-safety-and-health-list-of-hazardous-drugs the subject line your... Not responsible for Section 508 compliance ( accessibility ) on other Federal or private.! Your email request that you find interesting on CDC.gov through third party social networking and other hazardous drugs ) the... Due to aggressive automated scraping of FederalRegister.gov and eCFR.gov, programmatic access to our Policy. Areas of Expertise, Discipline, or relevant Experience: you can always do so by to... Interesting on CDC.gov through third party social networking and other websites Settings, 2016pdf icon
niosh hazardous drug list 2020 pdf
